Resultado de búsqueda
Hace 14 horas · It is currently being studied in two Phase 3 double placebo ... InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million ... 1.33. 0.03 (2.37 ...
Hace 14 horas · At a current market cap of $162 million, this is clearly underappreciated and unrecognized by the market at the present time. For reference, company peer Kiniksa Pharmaceuticals (KNSA) now has a $1.4 billion market cap on expected sales of $360-$380 million for treating recurrent pericarditis, with single to low double-digit market penetration.
Hace 2 horas · BRISBANE, Calif., May 28, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious...
29 de may. de 2024 · This was followed by another randomized control trial in 2004 by Staats et al. that showed intrathecal ziconotide was effective for cancer and AIDS-related pain compared to placebo. Multiple prospective studies have been published showing that IDD is safe and effective for the treatment of cancer-associated pain compared to placebo or traditional comprehensive medical management [ 32 , 33 , 34 ...
Hace 3 horas · --News Direct--Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, has been attracting substantial interest from investors looking for opportunities in the biotech sector. ...
Hace 14 horas · This offer expires November 1, 2022, so ... of abdominal pain and discomfort and improved stool consistency in functional diarrhea patients when compared to placebo. ... PLEASE TURN OFF YOUR CAPS ...
Hace 14 horas · Plymouth, IN (46563) Today. Partly cloudy with afternoon showers or thunderstorms. High 71F.
